search
Back to results

Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias (COBRA-PATH)

Primary Purpose

Tachycardia; Paroxysmal, Supraventricular, Tachycardia, Supraventricular

Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Standard catheter ablation
Contact Force-sensing-based catheter ablation
Sponsored by
Erasmus Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tachycardia; Paroxysmal, Supraventricular

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Referral for electrophysiology study because of pre-excitation on 12-lead surface ECG and/or documented (or suspected) symptomatic PSVT
  • Identification of AVNRT or WPW-AVRT (with manifest or concealed accessory pathway) during standard EP study
  • Verbal consent to continue with ablation therapy
  • Informed written consent to be included in the study

Exclusion Criteria:

  • evidence of structural heart disease and/or myocardial ischemia
  • pregnancy (and lack of exclusion of potential pregnancy)
  • age below 18 years

Sites / Locations

  • Erasmus MC

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

CONVENTIONAL group

CONTACT-FORCE group

Arm Description

Patients with supraventricular tachycardia treated with radiofrequency ablation using a standard (non-contact-force sensing) ablation catheter

Patients with supraventricular tachycardia treated with radiofrequency ablation using a Contact-Force-sensing ablation catheter

Outcomes

Primary Outcome Measures

Number of radiofrequency applications
The number of radiofrequency applications during the ablation procedures of AVNRT and WPW-AVRT

Secondary Outcome Measures

Overall duration of radiofrequency applications
total of time spend from the beginning till the end of the ablation procedure
Long-term procedural success
Free from recurrence of pre-excitation or the same clinical type of paroxysmal supraventricular tachycardia (AVNRT or AVRT)
Acute procedural success/failure
non-inducibility of clinical arrhythmia verified at the end of the standard EP study
Fluoroscopy time
total time for fluoroscopy time
Total duration of procedure
total time for duration of the procedure
(Serious) Adverse Events
all reported SAEs
Time to recurrence of AVNRT/WPW-AVRT
if recurrence of AVNRT/WPW-AVRT, time to recurrence

Full Information

First Posted
September 2, 2019
Last Updated
September 1, 2020
Sponsor
Erasmus Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04078685
Brief Title
Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias
Acronym
COBRA-PATH
Official Title
Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Unknown status
Study Start Date
June 12, 2018 (Actual)
Primary Completion Date
March 9, 2020 (Actual)
Study Completion Date
March 20, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Erasmus Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this single-center prospective randomized controlled trial is to assess the superiority of contact-force-(CF)-sensing-based approach compared to conventional (non-CF-sensing) approach in the catheter ablation of PSVTs, and to investigate the safety of open-irrigated, contact-force-sensing ablation catheters (used in a "non-irrigated" mode) in these procedures.
Detailed Description
Rationale: Multiple studies have demonstrated the importance of adequate catheter-tissue contact in the creation of effective lesions during radiofrequency catheter ablation. The development of contact-force(CF)-sensing catheters have contributed significantly to improve clinical outcomes in atrial fibrillation 3-18. However CF-sensing technology is not used in the ablation of paroxysmal supraventricular tachycardia. Although PSVT ablation with the conventional approach (non-irrigated, non-CF-sensing catheters) is considered a relatively low-risk procedure with fairly high success rate (short-and long-term) 1,2,19, we hypothesize that contact-force sensing can further improve the outcomes of these procedures. Based on the results of studies on atrial fibrillation ablation (mentioned above) we believe that CF-sensing could similarly improve such important parameters as radiofrequency (RF) application number/time, total procedure time, and fluoroscopy time in cases of PSVT ablations, as well. In addition CF-sensing could also further improve acute success/recurrence rates of PSVT ablation, and might also be capable to further diminish complication risk. Primary Objective: The primary objective of the present study is to demonstrate the superiority of contact-force-sensing in the ablation of AVNRT and WPW-AVRT as assessed by the improvement in the number and duration of radiofrequency applications compared with the conventional ablation approach. Secondary Objective: Secondary objectives of the study are the followings: to demonstrate that contact-force-sensing catheters are superior in terms of total procedure duration and fluoroscopy times in the case of AVNRT/WPW-AVRT ablation. to show that the use of contact-force sensing catheters is non-inferior to conventional catheters (without contact-force-sensing) in terms of acute/long-term procedural success and procedural safety (major/minor complication rate) of AVNRT/WPW-AVRT ablations. Study population: All patients above 18 years without structural heart disease being referred for electrophysiological study and potential treatment with radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT) with manifest (WPW syndrome) or concealed accessory pathways. Intervention: One group undergoes manual ablation using standard non-irrigated ablation catheters and the other group undergoes manual ablation with an open-irrigated ablation catheter equipped with CF- sensing (and utilized in a non-irrigated mode during ablation) Main study parameters/endpoints: The main study endpoint is the difference in RF application number during the procedures of AVNRT/WPW-AVRT ablation; secondary endpoints are differences in RF application rate, acute success rate, long-term recurrence rate (1 year) major/minor complication rate, and total procedure/fluoroscopy time.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tachycardia; Paroxysmal, Supraventricular, Tachycardia, Supraventricular

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
113 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CONVENTIONAL group
Arm Type
Active Comparator
Arm Description
Patients with supraventricular tachycardia treated with radiofrequency ablation using a standard (non-contact-force sensing) ablation catheter
Arm Title
CONTACT-FORCE group
Arm Type
Experimental
Arm Description
Patients with supraventricular tachycardia treated with radiofrequency ablation using a Contact-Force-sensing ablation catheter
Intervention Type
Procedure
Intervention Name(s)
Standard catheter ablation
Intervention Description
Radiofrequency catheter ablation using a standard ablation catheters: not equipped with contact-force sensing
Intervention Type
Procedure
Intervention Name(s)
Contact Force-sensing-based catheter ablation
Intervention Description
Radiofrequency catheter ablation using a Contact-Force-sensing ablation catheter
Primary Outcome Measure Information:
Title
Number of radiofrequency applications
Description
The number of radiofrequency applications during the ablation procedures of AVNRT and WPW-AVRT
Time Frame
From the beginning till the end of the ablation procedure
Secondary Outcome Measure Information:
Title
Overall duration of radiofrequency applications
Description
total of time spend from the beginning till the end of the ablation procedure
Time Frame
From the beginning till the end of the ablation procedure
Title
Long-term procedural success
Description
Free from recurrence of pre-excitation or the same clinical type of paroxysmal supraventricular tachycardia (AVNRT or AVRT)
Time Frame
At 12 months
Title
Acute procedural success/failure
Description
non-inducibility of clinical arrhythmia verified at the end of the standard EP study
Time Frame
at the end of the ablation procedure
Title
Fluoroscopy time
Description
total time for fluoroscopy time
Time Frame
From the beginning till the end of the ablation procedure
Title
Total duration of procedure
Description
total time for duration of the procedure
Time Frame
From the beginning till the end of the ablation procedure
Title
(Serious) Adverse Events
Description
all reported SAEs
Time Frame
Till 12 months
Title
Time to recurrence of AVNRT/WPW-AVRT
Description
if recurrence of AVNRT/WPW-AVRT, time to recurrence
Time Frame
up till 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Referral for electrophysiology study because of pre-excitation on 12-lead surface ECG and/or documented (or suspected) symptomatic PSVT Identification of AVNRT or WPW-AVRT (with manifest or concealed accessory pathway) during standard EP study Verbal consent to continue with ablation therapy Informed written consent to be included in the study Exclusion Criteria: evidence of structural heart disease and/or myocardial ischemia pregnancy (and lack of exclusion of potential pregnancy) age below 18 years
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tamas Szili-Torok, MD, PhD
Organizational Affiliation
Erasmus Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Erasmus MC
City
Rotterdam
ZIP/Postal Code
3015 GD
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25220575
Citation
Ullah W, Hunter RJ, Haldar S, McLean A, Dhinoja M, Sporton S, Earley MJ, Lorgat F, Wong T, Schilling RJ. Comparison of robotic and manual persistent AF ablation using catheter contact force sensing: an international multicenter registry study. Pacing Clin Electrophysiol. 2014 Nov;37(11):1427-35. doi: 10.1111/pace.12501. Epub 2014 Sep 15.
Results Reference
background
PubMed Identifier
24550405
Citation
Gerstenfeld EP. Contact force-sensing catheters: evolution or revolution in catheter ablation technology? Circ Arrhythm Electrophysiol. 2014 Feb;7(1):5-6. doi: 10.1161/CIRCEP.114.001424. No abstract available.
Results Reference
background
PubMed Identifier
26391136
Citation
Shurrab M, Di Biase L, Briceno DF, Kaoutskaia A, Haj-Yahia S, Newman D, Lashevsky I, Nakagawa H, Crystal E. Impact of Contact Force Technology on Atrial Fibrillation Ablation: A Meta-Analysis. J Am Heart Assoc. 2015 Sep 21;4(9):e002476. doi: 10.1161/JAHA.115.002476.
Results Reference
background
PubMed Identifier
26041872
Citation
Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, Skoda J, Wichterle D, Wissner E, Yulzari A, Kuck KH. EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace. 2015 Aug;17(8):1229-35. doi: 10.1093/europace/euv057. Epub 2015 Jun 3.
Results Reference
background
PubMed Identifier
24657428
Citation
Kimura M, Sasaki S, Owada S, Horiuchi D, Sasaki K, Itoh T, Ishida Y, Kinjo T, Tomita H, Okumura K. Comparison of lesion formation between contact force-guided and non-guided circumferential pulmonary vein isolation: a prospective, randomized study. Heart Rhythm. 2014 Jun;11(6):984-91. doi: 10.1016/j.hrthm.2014.03.019. Epub 2014 Mar 18.
Results Reference
background
PubMed Identifier
21872560
Citation
Kuck KH, Reddy VY, Schmidt B, Natale A, Neuzil P, Saoudi N, Kautzner J, Herrera C, Hindricks G, Jais P, Nakagawa H, Lambert H, Shah DC. A novel radiofrequency ablation catheter using contact force sensing: Toccata study. Heart Rhythm. 2012 Jan;9(1):18-23. doi: 10.1016/j.hrthm.2011.08.021. Epub 2011 Aug 26.
Results Reference
background
PubMed Identifier
22946636
Citation
Martinek M, Lemes C, Sigmund E, Derndorfer M, Aichinger J, Winter S, Nesser HJ, Purerfellner H. Clinical impact of an open-irrigated radiofrequency catheter with direct force measurement on atrial fibrillation ablation. Pacing Clin Electrophysiol. 2012 Nov;35(11):1312-8. doi: 10.1111/j.1540-8159.2012.03503.x. Epub 2012 Sep 4.
Results Reference
background
PubMed Identifier
25125294
Citation
Natale A, Reddy VY, Monir G, Wilber DJ, Lindsay BD, McElderry HT, Kantipudi C, Mansour MC, Melby DP, Packer DL, Nakagawa H, Zhang B, Stagg RB, Boo LM, Marchlinski FE. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol. 2014 Aug 19;64(7):647-56. doi: 10.1016/j.jacc.2014.04.072.
Results Reference
background
PubMed Identifier
32272969
Citation
Geczy T, Ramdat Misier NL, Szili-Torok T. Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias (COBRA-PATH): a randomized controlled trial. Trials. 2020 Apr 9;21(1):321. doi: 10.1186/s13063-020-4219-1.
Results Reference
derived

Learn more about this trial

Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias

We'll reach out to this number within 24 hrs